MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study-Reference-Cited by-同舟云学术

MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study

Published:2017-10 Issue:5 Volume:27 Page:439-447
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Guadagni Stefano,Fiorentini Giammaria,Clementi Marco,Palumbo Giancarlo,Masedu Francesco,Deraco Marcello,De Manzoni Giovanni,Chiominto Alessandro,Valenti Marco,Pellegrini Cristina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference27 articles.

1. The state of melanoma: challenges and opportunities;Merlino;Pigment Cell Melanoma Res,2016

2. Regional chemotherapy for cancer: experiences with 116 perfusions;Stehlin;Ann Surg,1960

3. Value of perfusion in pelvic surgery;Ryan;Dis Colon Rectum,1963

4. Isolated limb infusion with melphalan for recurrent melanoma: a simple alternative to isolated limb perfusion;Thompson;Reg Cancer Treat,1994

5. Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique;Wanebo;Ann Surg Oncol,1996

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of O6‐methylguanine‐DNA‐methyltransferase (MGMT) by lomeguatrib reduces multiple myeloma cell viability and impairs DNA repair in MGMT‐proficient cells;Chemical Biology & Drug Design;2024-01-29

2. Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy;Cancers;2021-12-10

3. A Prospective Study of Intraarterial Infusion Chemotherapy in Advanced Wild-Type BRAF Melanoma Patients;Journal of Surgical Research;2021-12

4. A systematic review of inter-individual differences in the DNA repair processes involved in melphalan monoadduct repair in relation to treatment outcomes;Cancer Chemotherapy and Pharmacology;2021-08-04

5. Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications;International Journal of Molecular Sciences;2021-04-27